[1]
“EVALUATION OF BIODEGRADABLE NANOCARRIERS FOR TARGETED DRUG DELIVERY IN HEPATOCELLULAR CARCINOMA”, FMHR, vol. 3, no. 7, pp. 1259–1272, Sep. 2025, Accessed: Apr. 23, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1225